Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiro Takemasa

Showing results (171-180 of 345) with videos related to

Pageof 35
Sort By:
Anticancer Research|March 27, 2024
CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV Colorectal Cancer SurvivalTetsuta Satoyoshi, Yoshihiko Hirohashi, Koichi Okuya, et al.
Cancer Science|March 13, 2012
C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancerRyota Oshiro, Hirofumi Yamamoto, Hidekazu Takahashi, et al.
Oncology|July 3, 2019
A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal CancerToshihiro Kudo, Ichiro Takemasa, Tsuyoshi Hata, et al.
Annals of Surgical Oncology|July 14, 2010
Exploration of potential genomic portraits associated with intrahepatic recurrence in human hepatocellular carcinomaNobuyoshi Kittaka, Ichiro Takemasa, Shigeto Seno, et al.
Genome Biology|March 7, 2003
Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression dataShizuko Muro, Ichiro Takemasa, Shigeyuki Oba, et al.
Surgery Today|October 1, 2016
Safety and efficacy of an "enhanced recovery after surgery" protocol for patients undergoing colon cancer surgery: a multi-institutional controlled studyHirofumi Ota, Masakazu Ikenaga, Junichi Hasegawa, et al.
Cancer Chemotherapy and Pharmacology|November 9, 2018
A dose-escalation study of docetaxel, oxaliplatin, and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancerYasushi Sato, Tamotsu Sagawa, Hiroyuki Ohnuma, et al.
Journal of Gastroenterology|July 31, 2024
The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trialAtsushi Hamabe, Ichiro Takemasa, Masayuki Ishii, et al.
Surgical Case Reports|September 5, 2023
World-first report of low anterior resection for rectal cancer with the hinotori™ Surgical Robot System: a case reportRyo Miura, Koichi Okuya, Emi Akizuki, et al.
Surgery Today|December 30, 2015
(18)F-Fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancerJunichi Nishimura, Junichi Hasegawa, Yoji Ogawa, et al.
Pageof 35

Showing results (171-180 of 345) with videos related to

Sort By:
Pageof 35
Anticancer Research|March 27, 2024
CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV Colorectal Cancer SurvivalTetsuta Satoyoshi, Yoshihiko Hirohashi, Koichi Okuya, et al.
Cancer Science|March 13, 2012
C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancerRyota Oshiro, Hirofumi Yamamoto, Hidekazu Takahashi, et al.
Oncology|July 3, 2019
A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal CancerToshihiro Kudo, Ichiro Takemasa, Tsuyoshi Hata, et al.
Annals of Surgical Oncology|July 14, 2010
Exploration of potential genomic portraits associated with intrahepatic recurrence in human hepatocellular carcinomaNobuyoshi Kittaka, Ichiro Takemasa, Shigeto Seno, et al.
Genome Biology|March 7, 2003
Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression dataShizuko Muro, Ichiro Takemasa, Shigeyuki Oba, et al.
Surgery Today|October 1, 2016
Safety and efficacy of an "enhanced recovery after surgery" protocol for patients undergoing colon cancer surgery: a multi-institutional controlled studyHirofumi Ota, Masakazu Ikenaga, Junichi Hasegawa, et al.
Cancer Chemotherapy and Pharmacology|November 9, 2018
A dose-escalation study of docetaxel, oxaliplatin, and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancerYasushi Sato, Tamotsu Sagawa, Hiroyuki Ohnuma, et al.
Journal of Gastroenterology|July 31, 2024
The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trialAtsushi Hamabe, Ichiro Takemasa, Masayuki Ishii, et al.
Surgical Case Reports|September 5, 2023
World-first report of low anterior resection for rectal cancer with the hinotori™ Surgical Robot System: a case reportRyo Miura, Koichi Okuya, Emi Akizuki, et al.
Surgery Today|December 30, 2015
(18)F-Fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancerJunichi Nishimura, Junichi Hasegawa, Yoji Ogawa, et al.
Pageof 35